메뉴 건너뛰기




Volumn 28, Issue 5, 2004, Pages 371-374

Managing methotrexate toxicity: A case report;Manejo de la intoxicación por metotrexato: A propósito de un caso

Author keywords

Methotrexate; Monitoring; Toxicity

Indexed keywords

BICARBONATE; COLESTYRAMINE; DIURETIC AGENT; FOLINIC ACID; FUROSEMIDE; GLUCOSE; MANNITOL; METHOTREXATE;

EID: 9244251022     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (6)

References (14)
  • 1
    • 0027980646 scopus 로고
    • Patient characteristics associated with high-risk methotrexate concentrations and toxicicy
    • Relling MV, Fairclough D, Ayers D, Crom R, Rodman JH, Ching-Hon Pui, et al. Patient characteristics associated with high-risk methotrexate concentrations and toxicicy. J Clin Oncol 1994; 8: 1667-72.
    • (1994) J Clin Oncol , vol.8 , pp. 1667-1672
    • Relling, M.V.1    Fairclough, D.2    Ayers, D.3    Crom, R.4    Rodman, J.H.5    Pui, C.-H.6
  • 2
    • 0033621556 scopus 로고    scopus 로고
    • Individualized methotrexate dosing in children with relapsed acute lymphoblastic leukemia
    • Wall AM, Gajjar A, Link A, Mahmoud H, Pui CH, Relling MV. Individualized methotrexate dosing in children with relapsed acute lymphoblastic leukemia. Leukemia 2000; 14 (2): 221-5.
    • (2000) Leukemia , vol.14 , Issue.2 , pp. 221-225
    • Wall, A.M.1    Gajjar, A.2    Link, A.3    Mahmoud, H.4    Pui, C.H.5    Relling, M.V.6
  • 4
    • 0003785851 scopus 로고    scopus 로고
    • Micromedex Inc. Denver, Colorado. Drug Evaluation Methotrexate
    • DrugDex® Information System. Micromedex Inc. Denver, Colorado 2000. Drug Evaluation Methotrexate.
    • (2000) DrugDex® Information System
  • 5
    • 0025163171 scopus 로고
    • Rescue after intermediate and high-dose methotrexate: Background, rationale and current practice
    • Borsi JD, Sagen E, Romslo I, Moe PJ. Rescue after intermediate and high-dose methotrexate: background, rationale and current practice. Pediatric Hematology and Oncology 1990; 7: 374-63.
    • (1990) Pediatric Hematology and Oncology , vol.7 , pp. 374-363
    • Borsi, J.D.1    Sagen, E.2    Romslo, I.3    Moe, P.J.4
  • 7
    • 0031806321 scopus 로고    scopus 로고
    • Succesful rescue in a patient with high dose methotrexate-induced nephrotoxicity and acute renal failure
    • Kepka L, De Lassence A, Ribrag V, Gachot B, Blot F, Theodore C, et al. Succesful rescue in a patient with high dose methotrexate-induced nephrotoxicity and acute renal failure. Leuk Lymphoma 1998; 29 (1-2): 205-9.
    • (1998) Leuk Lymphoma , vol.29 , Issue.1-2 , pp. 205-209
    • Kepka, L.1    De Lassence, A.2    Ribrag, V.3    Gachot, B.4    Blot, F.5    Theodore, C.6
  • 8
    • 0033304167 scopus 로고    scopus 로고
    • Prediction of methotrexate elimination after high dose infusion in children with acute lymphoblastic leukaemia using a population pharmacokinetic approach
    • Abstract
    • Odoul F, Le Guellec C, Lamagnere JP, Breilh D, Saux MC, Paintaud G, et al. Prediction of methotrexate elimination after high dose infusion in children with acute lymphoblastic leukaemia using a population pharmacokinetic approach. (Abstract) Fundam Clin Pharmacol 1999; 13(5): 495-604.
    • (1999) Fundam Clin Pharmacol , vol.13 , Issue.5 , pp. 495-604
    • Odoul, F.1    Le Guellec, C.2    Lamagnere, J.P.3    Breilh, D.4    Saux, M.C.5    Paintaud, G.6
  • 10
    • 0036035302 scopus 로고    scopus 로고
    • Bayesian estimation of methotrexate pharmacokinetic parameters and area under the curve in children and young adults with localised osteosarcoma
    • Rousseau A, Sabot C, Delepine N, Delepine G, Debord J, Lachatre G, et al. Bayesian estimation of methotrexate pharmacokinetic parameters and area under the curve in children and young adults with localised osteosarcoma. Clin Pharmacokinet 2002; 41 (13): 1095-104.
    • (2002) Clin Pharmacokinet , vol.41 , Issue.13 , pp. 1095-1104
    • Rousseau, A.1    Sabot, C.2    Delepine, N.3    Delepine, G.4    Debord, J.5    Lachatre, G.6
  • 11
    • 0035987504 scopus 로고    scopus 로고
    • Bayesian population model of methotrexate to guide dosage adjustments for folate rescue in patients with breast cancer
    • Monjanel-Mouterde S, Lejeune C, Ciccolini J, Merite N, Hadjaj D, Bonnier P, et al. Bayesian population model of methotrexate to guide dosage adjustments for folate rescue in patients with breast cancer. J Clin Pharm Ther 2002; 27 (3): 189-95.
    • (2002) J Clin Pharm Ther , vol.27 , Issue.3 , pp. 189-195
    • Monjanel-Mouterde, S.1    Lejeune, C.2    Ciccolini, J.3    Merite, N.4    Hadjaj, D.5    Bonnier, P.6
  • 13
    • 0030611877 scopus 로고    scopus 로고
    • Carboxypeptidasa-G2, thymidine, and leucovorin rescue in cancer patients with methtrexate-induced renal dysfunction
    • Widemann BC, Balis PM, Murphy RF, Sorensen JM, Montello MJ, O'Brien M, et al. Carboxypeptidasa-G2, thymidine, and leucovorin rescue in cancer patients with methtrexate-induced renal dysfunction. J Clin Oncol 1997; 15 (5): 2125-34.
    • (1997) J Clin Oncol , vol.15 , Issue.5 , pp. 2125-2134
    • Widemann, B.C.1    Balis, P.M.2    Murphy, R.F.3    Sorensen, J.M.4    Montello, M.J.5    O'Brien, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.